Advanced company searchLink opens in new window

RXBIOLOGICS LIMITED

Company number 10590235

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Aug 2024 AA Accounts for a small company made up to 30 November 2023
11 Feb 2024 CS01 Confirmation statement made on 29 January 2024 with no updates
08 Aug 2023 AA Accounts for a small company made up to 30 November 2022
12 Jul 2023 CH01 Director's details changed for Dr Elaine Mckilligin on 12 July 2023
12 Jul 2023 CH01 Director's details changed for Dr Jill Reckless on 12 July 2023
12 Jul 2023 CH03 Secretary's details changed for Dr Elaine Mckilligin on 12 July 2023
12 Jul 2023 CH01 Director's details changed for Dr David John Grainger on 12 July 2023
08 Feb 2023 MR04 Satisfaction of charge 105902350001 in full
06 Feb 2023 CS01 Confirmation statement made on 29 January 2023 with no updates
06 May 2022 AA Accounts for a small company made up to 30 November 2021
02 Feb 2022 CS01 Confirmation statement made on 29 January 2022 with no updates
14 Jul 2021 AA Total exemption full accounts made up to 30 November 2020
09 Feb 2021 CS01 Confirmation statement made on 29 January 2021 with no updates
19 Oct 2020 AD01 Registered office address changed from B950 Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3AT England to The Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3FH on 19 October 2020
12 Oct 2020 AA Total exemption full accounts made up to 30 November 2019
15 Aug 2020 AD01 Registered office address changed from C/O C/O Rxcelerate Limited Moneta Building Babraham Research Campus Babraham Cambridge CB22 3AT United Kingdom to B950 Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3AT on 15 August 2020
25 Jun 2020 MR01 Registration of charge 105902350001, created on 19 June 2020
10 Feb 2020 CS01 Confirmation statement made on 29 January 2020 with updates
07 Aug 2019 SH01 Statement of capital following an allotment of shares on 29 July 2019
  • GBP 1,000
06 Aug 2019 AP01 Appointment of William James Jonathan Finlay as a director on 29 July 2019
31 Jul 2019 AA Total exemption full accounts made up to 30 November 2018
16 Apr 2019 SH06 Cancellation of shares. Statement of capital on 29 March 2019
  • GBP 800
16 Apr 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Cancel 79,200 ordinary shares 29/03/2019
07 Feb 2019 CS01 Confirmation statement made on 29 January 2019 with updates
07 Feb 2019 RESOLUTIONS Resolutions
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2019-01-15